John and Doves,

Italy Evaluating VeriChip Healthcare Application in Rome, Italy (VeriMed) -- April 26, 2004
Study To Begin at Instituto Nazionale Lazzaro Spallanzani Hospital on April 26th
The principal investigator, Dr. Giorgio Antonucci, presented the study's protocol to the Italian Ministry of Health and has received approval to proceed. The study is designed to observe the VeriMed(TM) technology function during care provided to patients whose medical conditions impede conveying vital information to the hospital's medical staff. Patients will be given the opportunity to utilize the VeriMed(TM) technology to provide their personal identification information and recent medical history. Dr. Antonucci and his staff are expected to begin patient enrollment in the program immediately. It is anticipated that the objectives of the study will be realized in six months, at which time the findings will be presented to the Italian Ministry of Health.
The logistics and technical support for the study in Rome are being provided by Biotronica SRL, a subsidiary of Fanara And Associates SRL, the exclusive VeriChip distributor for Italy.
http://biz.yahoo.com/bw/040426/265500_1.html
 

Vice - President  Dr. Richard Seelig
 VeriMed’s many potential healthcare-related uses include the following:
**Implanted medical device identification (Ed. note: VeriChip)
Emergency access to patient-supplied health information (Ed. note: interconnected databases)
Portable medical records access
In-hospital patient identification
Medical facility connectivity via patient
Patient/therapy integration
Inter-facility patient identification
Disease/treatment management of at-risk populations (e.g. vaccination history)
http://www.adsx.com/news/2003/102903.html

---

more info at www.cybertime.net/~ajgood/medchip.html